Lentiviral Vectors Market is Estimated to Witness High Growth Owing to Rising Gene Therapy Adoption
Lentiviral Vectors Market |
Lentiviral vectors are used as delivery vehicles for gene therapy as they can efficiently and stably deliver therapeutic genes into the nucleus. They have emerged as an important tool for integrating genes into the genomes of non-dividing cells. Growing application in cell and gene therapy to treat genetic disorders like HIV/AIDS, neurological disorders, and cancer is expected to drive the demand for lentiviral vectors.
The
global lentiviral vectors market is estimated to be valued at US$ 336.39 Bn in
2024 and is expected to exhibit a CAGR of 13% over the forecast period from
2024 to 2031.
Key Takeaways
Key players operating in the lentiviral vectors market are Tata Communications
Ltd., Amazon CloudFront €“ Amazon.com Inc., Cachefly, CDNetworks Co., Ltd.,
CDNify Ltd., CDNsun, CDNvideo, CloudFlare, Inc., EdgeCast Networks, Fastly,
Proinity LLC, Limelight Networks Inc., Skypark CDN, and Level 3 Communication
Inc. The market represents significant opportunities in gene therapy
development as lentiviral vectors are increasingly being adopted for developing
novel therapies. Major players are focusing on expansion in North America and
Europe owing to higher healthcare expenditures and greater acceptance of novel
treatment options in these regions.
Key players:
Key players operating in the lentiviral vectors market are Tata Communications
Ltd., Amazon CloudFront – Amazon.com Inc., Cachefly, CDNetworks Co., Ltd.,
CDNify Ltd., CDNsun, CDNvideo, CloudFlare, Inc., EdgeCast Networks, Fastly,
Proinity LLC, Limelight Networks Inc., Skypark CDN, and Level 3 Communication
Inc.
Key opportunities:
The market represents significant opportunities in gene therapy development as Lentiviral
Vectors Market Size are increasingly being adopted for developing novel
therapies. Major private and public investments in cell and gene therapy
research is another factor expected to contribute to market opportunities.
Global expansion:
Major players are focusing on expansion in North America and Europe owing to
higher healthcare expenditures and greater acceptance of novel treatment options
in these regions. Strategic collaborations with research institutes and
emerging players in Asia Pacific are also expected to help companies strengthen
their presence in high growth markets.
Market drivers:
Increasing incidence of genetic disorders and rising investment in gene therapy
research are some of the major factors driving the demand for lentiviral
vectors. Growing application of lentiviral vectors in developing highly
effective therapies for conditions like cancer, cardiovascular diseases, and
neurological disorders is expected to provide impetus to market growth over the
forecast period.
PEST Analysis
Political: Governments increasingly invest in gene therapy research &
regulate biosafety laws for clinical trials to accelerate development of
lentiviral vectors.
Economic: Steady investments from pharma & research organizations to
commercialize lentiviral
vectors market Size and trends . Cost-effective production also boosts
adoption.
Social: Increasing prevalence of genetic & infectious diseases raises
awareness and acceptance of advanced treatment methods involving gene therapy
with minimal ethical concerns.
Technological: Improvements in vector constructs, targeting ability, scalable
production processes and analytics lower technical barriers and facilitate
clinical research in applications like cancer gene therapy and vaccination
development using lentiviral vectors.
Geographical Regions with High Market Concentration
North America has the largest share of the global lentiviral vectors market due
to presence of advanced research infrastructure and supportive government
funding for development activities. Presence of leading pharmaceutical
companies and research institutions also drive regional market growth.
Fastest Growing Region
The Asia Pacific region is expected to witness highest growth during the
forecast period owing to rising government and private investments to establish
gene therapy manufacturing facilities and expanding healthcare infrastructure
in emerging countries like China and India. Rising disease burden and growing
medical tourism also boost regional market demand.
Get
more insights on – Lentiviral
Vectors Market
About Author:
Money Singh
is a seasoned content writer with over four years of experience in the market
research sector. Her expertise spans various industries, including food and
beverages, biotechnology, chemical and materials, defense and aerospace,
consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
Comments
Post a Comment